Corticotrophin-releasing hormone receptor type 1: Generation and characterization of polyclonal antipeptide antibodies and their localization in pituitary cells and cortical neurones in vitro

Journal of Neuroendocrinology

Volumn 8, Issue 7, 1996, Pages 521-531

  Castro, M G ^a   Morrison, E ^a   Perone, M J ^a   Brown, O A ^a,c   Murray, C A ^a   Ahmed, I ^b   Perkins, A V ^b   Europe Finner, G ^b   Lowenstein, P R ^a   Linton, E A ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

Author keywords

Anterior pituitary; AtT20; CRH receptor 1 antiserum; Neurones

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; POLYCLONAL ANTIBODY;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CEREBELLUM; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MYOMETRIUM; NERVE CELL CULTURE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STRESS; TARGET CELL;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELL LINE; CEREBRAL CORTEX; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNE SERA; NEURONS; PEPTIDE FRAGMENTS; PITUITARY GLAND; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TISSUE DISTRIBUTION;

EID: 8944262045     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04866.x     Document Type: Article

References (42)

1. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotrophin and β-endorphin. Science 1981; 213: 1394-1397.
2. Linton EA, Lowry PJ. Corticotrophin releasing factor in man and its measurement: a review. Clin Endocr 1989; 31: 225-249.
3. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA 1993; 90: 8967-8971.
4. Chang C-P, Pearse II RV, O'Connel S, Rosenfeld MG. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 1993; 11: 1187-1195.
5. Perrin M, Donaldson C, Chen R, et al. Identification of a second CRF receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995; 92: 2969-2973.
6. Ross PC, Kostas CM, Ramabhadran TV. A variant of the human corticotropin-releasing factor receptor: cloning, expression and pharmacology. Biochem Biophys Res Comm 1994; 205: 1836-1842.
7. Potter E, Sutton S, Donaldson C, et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994; 91: 8777-8781.
8. Lovenberg TW, Liaw CW, Grigoriadis DE, et al. Cloning and characterisation of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995a; 92: 836-840.
9. Kishimoto T, Pearse II RV, Lin CR, Rosenfeld MG. A sauvagine/ corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995; 92: 1108-1112.
10. Vaughan J, Donaldson C, Bittencourt J, et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to CRF. Nature 1995; 378: 287-292.
11. Lovenberg TW, Chalmers DT, Liu C, De Souza EB. CRF-2α and CRF-2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995b; 136: 4139-4142.
12. Dieterich KD, Grigoriadis DE, De Souza EB. Characterization of corticotrophin releasing factor receptors from human small cell lung carcinoma (SCLC). Soc Neurosci Abstr 1994; 20: 552-556.
13. Reynolds, PJ, Grigoriadis DE, Lovenberg TW, et al. Presence of CRF receptors on human peripheral blood cells and monocyte lines. Soc Neurosci Abstr 1994; 20: 552.9.
14. Perkins AV, Eben F, Wolfe CDA, Schulte HM, Linton EA. Plasma measurements of Corticotrophin Releasing Hormone-Binding Protein in normal and abnormal human pregnancy. J Endocr 1993; 138: 149-157.
15. Castro MG, Rowe J, Shering A, et al. Generation and characterization of an antiserum reactive with a proteolytic processing site within rat procorticotrophin-releasing hormone. Neuropeptides 1995; 29: 183-192.
16. Rosendale B E, Jarret DB, Robinson AG. Identification of a corticotropin-releasing factor binding protein in the plasma membrane of AtT20 mouse pituitary tumour cells and its regulation by dexamethasone. Endocrinology 1987; 120: 2357-2366.
17. Labrie F, Veilleux R, Lefevre G, Coy DH, Sueiras-Diaz J, Schally AV. Corticotropin-releasing factor stimulates accumulation of adenosine 3′,5′-monophosphate in rat pituitary corticotrophs. Science 1982; 216: 1007-1008.
18. Reisine T, Heisler S, Hook VY, Axelrod J. Multireceptor induced release of adrenocortin from anterior pituitary tumour cells. Biochem Biophys Res Comm 1982; 108: 1251-1257.
19. Wynn PC, Aguilera G, Morell G, Catt KJ. Properties and regulation of high affinity pituitary receptors for corticotropin releasing factor. Biochem Biophys Res Comm 1983; 110: 602-608.
20. Castro MG, Gusovsky F, Loh YP. Transmembrane signals mediating adrenocorticotrophin release from mouse anterior pituitary cells. Mol Cell Endocrinol 1989; 65: 165-173.
21. Castro MG. Effects of corticotrophin releasing factor and arginine vasopressin on proopiomelanocortin mRNA levels, release and storage of adrenocorticotrophin from mouse anterior pituitary cells. Comp Biochem Physiol 1993; 104A: 105-112.
22. De Souza EB, Perrin MH, Insel TR, Rivier J, Vale WW, Kuhar MJ. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic detection. Science 1984; 224: 1449-1451.
23. De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW. Reciprocal changes in corticotropin-releasing factor(CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature 1986; 319: 593-595.
24. Rivera J, Lopez Bernal A, Varney M, Watson SP. Inositol 1,4,5-trisphosphate and oxytocin binding in human myometrium. Endocrinology 1990; 127: 155-162.
25. Philips WD, Maimone MM, Merlie JP. Mutagenesis of the 43 kDa post-synaptic protein defines domains involved in plasma membrane targeting and AChR clustering. J Cell Biol 1991; 115: 1713-1723.
26. Lowenstein P R, Morrison EE, Bain D, et al. Use of recombinant vectors derived from herpes simplex virus tsk for short term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic cortical neurons and glial cells in vitro. Neuroscience 1994a; 60: 1059-1077.
27. Lowenstein PR, Morrison EE, Bain D, et al. Polarized distribution of the trans-golgi network marker protein TGN38 during the in vitro development of neocortical neurons: effects of nocodazole and brefeldin A. Europ. J Neurosc 1994b; 6: 1453-1465.
28. Lowenstein PR, Morrison EE, Tomasec P, et al. Synapse formation in low density primary cultures of neocortex. J Neurocytol 1995; 24: 301-317.
29. Grigoriadis DE, De Souza EB. Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation. Endocrinology 1989; 125: 1877-1888.
30. Grigoriadis DE, De Souza EB. Corticotropin-releasing factor receptors in the intermediate lobe of the pituitary: biochemical characterisation and autoradiographic localisation. Peptides 1989a; 10: 179-188.
31. Webster E L, Grigoriadis DE, De Souza EB. Corticotropin-releasing factor receptors in the brain-pituitary-immune axis. In: McCubbin JA, Kaufmann PG, Nemeroff CB, eds. Stress, neuropeptides and systemic disease. Diego: San Diego, 1991: 233-260.
32. Grigoriadis DE, De Souza EB. The brain corticotropin releasing factor receptor is of lower apparent molecular weight the CRF receptor in anterior pituitary: evidence from chemical cross-linking studies. J Biol Chem 1988; 263: 10927-10931.
33. Flores M, Carvallo P, Aguilera G. Physiochemical characterization of the corticotropin-releasing factor receptor in rat pituitary and brain. Life Sci 1990; 47: 2035-2040.
34. Grigoriadis DE, Heroux JA, De Souza EB. Characterisation and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. In: Chadwick DJ, Marsh J, Ackrill K, eds. Corticotropin-releasing factor. Chichester: Wiley (Ciba Foundation Symposium) 1993; 172: 85-107.
35. Quattero H, Srivatsa G, Gillham B. Role for cyclic adenosine monophosphate in the synergistic interaction between oxytocin and CRH in isolated human gestational myometrium. Clin Endocrinol 1992; 36: 141-145.
36. Hillhouse EW, Grammatopoulos D, Milton N, Quartero H. The identification of a human myometrial CRH receptor which increases its affinity during pregnancy. J Clin Endocr Metab 1993; 76: 736-741.
37. Hillhouse E, Milton N, Grammatopoulos D, Quatero, H. The identification and characterisation of a human myometrial corticotropin-releasing factor 41 receptor which increases in affinity during pregnancy. J Endocrinol 1992; 132 (suppl): 303.
38. Grammatopoulos D, Thompson S, Hillhouse E.W. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J Clin Endocrinol Metabolism 1995; 80: 2388-2393.
39. Castro MG, Rowe J, Tomasec P, et al. Methods for introducing genes into neuronal and endocrine cell lines. In: Lowenstein, PR, Enquist LW, eds. Gene transfer into postmitotic neurons: towards gene therapy of human neurological disorders. Chichester: Wiley and Sons, 1996: 9-23.
40. Europe-Finner GN, Phaneuf S, Watson SP, Lopez Bernal A. Identification and expression of G proteins in human myometrium: upregulation of Gs in pregnancy. Endocrinology 1993; 132: 2484-2490.
41. Bradford MM. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of dye binding. Anal Biochem 1976; 72: 248-254.
42. 16-diphenyl glycouril(iodogen). Anal Biochem 1981; 117: 136-146.